1-12 of 12
Andrew Cowan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: Aquila outcomes based on mayo 2018/IMWG 2020 risk stratification, IMWG 2020 plus cytogenetic criteria, and age

Free
Peter Voorhees, Meletios Dimopoulos, Yaël Cohen, Fredrik Schjesvold, Vania Hungria, Irwindeep Sandhu, Jindriska Lindsay, Ross Baker, Kenshi Suzuki, Hiroshi Kosugi, Mark-David Levin, Meral Beksac, Keith Stockerl-Goldstein, Hila Magen, Albert Oriol, Gabor Mikala, Gonzalo Garate, Koen Theunissen, Ivan Špička, Anne Mylin, Simon Hallam, Sara Bringhen, Katarina Uttervall, Bartosz Pula, Abdullah Khan, Eva Medvedova, J Christine Ye, Andrew Cowan, Philippe Moreau, María-Victoria Mateos, Hartmut Goldschmidt, Diego Vieyra, Ashta Raval, Linlin Sha, Liang Li, Els Rousseau, Robyn Dennis, Robin Carson, S. Vincent Rajkumar
Journal: Blood
Blood (2025) 146 (Supplement 1): 372.
https://doi.org/10.1182/blood-2025-372
Published: 2025
Journal Articles

Short survival with BCMA and GPRC5D dual antigen exposed relapsed myeloma- an international myeloma working group immunotherapy database analysis

Free
Murali Janakiram, Thomas Martin, Mrugakshi Dave, Chiung-Yu Huang, Sireesha Asoori, Myo Htut, Andre De Menezes Silva Corraes, Prashant Kapoor, Chris Lau Wai Pan, Carlyn Tan, Saad Usmani, Hira Mian, Roman Hajek, Efstathios Kastritis, Susan Bal, Joaquin Martinez-Lopez, Andrew Cowan, Chandramouli Nagarajan, Wee-Joo Chng, Allison Tso, Hermann Einsele, Amrita Krishnan, Rakesh Popat, Yi Lin, Darren Pan
Journal: Blood
Blood (2025) 146 (Supplement 1): 4598.
https://doi.org/10.1182/blood-2025-4598
Published: 2025
Journal Articles

Dexamethasone dose intensity does not improve 6-month responses in newly diagnosed multiple myeloma and may contribute to hyperglycemia

Free
Gui Zhen Chen, Jenna Voutsinas, Qian Wu, Xiang Yu Gao, Ayushi Gupta, Rahul Banerjee, Andrew Cowan
Journal: Blood
Blood (2025) 146 (Supplement 1): 2207.
https://doi.org/10.1182/blood-2025-2207
Published: 2025
Journal Articles

A functional precision medicine clinical trial in Relapsed/Refractory multiple myeloma: Prospective study of a high throughput drug sensitivity assay on correlation of drug sensitivity scores with treatment response

Free
Raffaella Cassano Cassano, Timothy Martins, David Coffey, Gabriele Buda, Sara Galimberti, Ryan Donnelly, Mary Kwok, Damian Green, Rahul Banerjee, Kara Cicero, Ted Gooley, Rebecca Silbermann, Pamela Becker, Andrew Cowan
Journal: Blood
Blood (2025) 146 (Supplement 1): 7446.
https://doi.org/10.1182/blood-2025-7446
Published: 2025
Journal Articles

Adverse financial events and delayed treatment initiation among patients with hematologic malignancies

Free
Christopher Su, Li Li, Catherine Fedorenko, Andrew Cowan, Scott Ramsey, Veena Shankaran
Journal: Blood
Blood (2025) 146 (Supplement 1): 286.
https://doi.org/10.1182/blood-2025-286
Published: 2025
Journal Articles

Phase 1/2 dose escalation and expansion study of etentamig in patients with relapsed or refractory light chain amyloidosis

Free
Rajshekhar Chakraborty, Efstathios Kastritis, Antoine Huart, Arnaud Jaccard, Heather Landau, Shinsuke Iida, Olga Motorna, Peter Mollee, Tadao Ishida, Yawara Kawano, Manisha Bhutani, Anita D'Souza, Andrew Cowan, James Hoffman, Chetasi Talati, Tanya Rosenberg, Ross La Motte-Mohs, Fan Wang, David Hoffman, Mingwei Fei, Emma Arriola, Jovian Yu, Shaji Kumar, Angela Dispenzieri, Giovanni Palladini, Vaishali Sanchorawala
Journal: Blood
Blood (2025) 146 (Supplement 1): 692.
https://doi.org/10.1182/blood-2025-692
Published: 2025
Journal Articles

Long term safety and long term disease control of oral ixazomib and short-course rituximab in untreated iNHL

Free
Xiancheng Wu, Solomon Graf, Ryan Lynch, Chaitra Ujjani, Ted Gooley, Jenna Voutsinas, Heather Rasmussen, Wendy Felder, Kristi Matsumura, Andrew Cowan, Stephen Smith, Mazyar Shadman, Edus Warren, Jonathan Fromm, Ajay Gopal
Journal: Blood
Blood (2025) 146 (Supplement 1): 5355.
https://doi.org/10.1182/blood-2025-5355
Published: 2025
Journal Articles

Independent assessment of ALC thresholds currently in use to predict motor/neurocognitive toxicities (MNTs) after treatment with ciltacabtagene autoleucel

Free
Yein Jeon, Xiancheng Wu, Christy Khouderchah, Emily Liang, Andrew Portuguese, Jennifer Huang, Erik Kimble, Alexandre Hirayama, Mazyar Shadman, Andrew Cowan, Danai Dima, Rahul Banerjee, Madhav Dhodapkar, Lawrence Fong, Qian Wu, Meredith Durbin, Jordan Gauthier
Journal: Blood
Blood (2025) 146 (Supplement 1): 4147.
https://doi.org/10.1182/blood-2025-4147
Published: 2025
Journal Articles

Real world efficacy and safety of elranatamab, a BCMA bispecific antibody for patients with relapsed and refractory multiple myeloma: An international myeloma working group immunotherapy database analysis

Free
Rakesh Popat, Oliver Morjaria, Carlyn Tan, Saad Usmani, Alissa Visram, Susan Bal, Luciano Costa, Roman Hajek, Jana Mihalyova, Joaquin Martinez-Lopez, Adolfo Sáez Marín, Meletios Dimopoulos, Efstathios Kastritis, Chandramouli Nagarajan, Shimin Jasmine Chung, Myo Htut, Wee-Joo Chng, Allison Tso, Thomas Martin, Mrugakshi Dave, Chiung-Yu Huang, Andrew Cowan, Hermann Einsele, Yi Lin, Hira Mian
Journal: Blood
Blood (2025) 146 (Supplement 1): 4588.
https://doi.org/10.1182/blood-2025-4588
Published: 2025
Journal Articles

Selinexor, mezigdomide, and dexamethasone in patients with Relapsed/Refractory multiple myeloma who relapsed or are ineligible for T-cell–redirecting therapy: Stomp Phase 1 results

Free
Clifton Mo, Cristina Gasparetto, Cristiana Costa, Andrew Cowan, Tomer Mark, Yi Chai, Trinayan Kashyap, Jessica Katz, Michael Amatangelo, Paul Richardson
Journal: Blood
Blood (2025) 146 (Supplement 1): 4010.
https://doi.org/10.1182/blood-2025-4010
Published: 2025
Journal Articles

Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy

Available to Purchase
Clinical Trials & Observations
Binod Dhakal, Othman S. Akhtar, David Fandrei, Alexandria Jensen, Rahul Banerjee, Darren Pan, Shambavi Richard, Reed Friend, Matthew Rees, Patrick Costello, Mariola Vazquez Martinez, Oren Pasvolsky, Charlotte Wagner, James A. Davis, Omar Castaneda Puglianini, Ran Reshef, Aimaz Afrough, Danai Dima, Manisha Bhutani, Omar Nadeem, Ricardo Parrondo, Ciara Freeman, Lekha Mikkilineni, Shahzad Raza, Larry D. Anderson Jr, Prashant Kapoor, Hitomi Hosoya, Saurabh Chhabra, Ariel Grajales-Cruz, Mahmoud Gaballa, Shonali Midha, Melissa Alsina, Douglas Sborov, Krina Patel, Yi Lin, Christopher Ferreri, Nico Gagelmann, Anupama Kumar, Doris Hansen, Andrew Cowan, Luciano J. Costa, Maximilian Merz, Surbhi Sidana
Journal: Blood
Blood (2025) 146 (17): 2063–2072.
https://doi.org/10.1182/blood.2025029773
Published: 2025
Includes: Supplemental data
Journal Articles

Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Available to Purchase
Clinical Trials & Observations
Rajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, Divaya Bhutani, Morie A. Gertz, Angela Dispenzieri, Shaji Kumar, Anita D’Souza, Anannya Patwari, Andrew Cowan, GuiZhen Chen, Paolo Milani, Giovanni Palladini, Vaishali Sanchorawala, Geethika Bodanapu, Stefan O. Schönland, Suzanne Lentzsch, Eli Muchtar
Journal: Blood
Blood (2024) 144 (25): 2613–2624.
https://doi.org/10.1182/blood.2024025899
Published: 2024
Includes: Supplemental data